National Health (Weighted average disclosed price – April 2019 reduction day) Amendment Determination 2019
National Health Act 1953
I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated: 19 February 2019
ADRIANA PLATONA
First Assistant Secretary
Technology Assessment and Access Division
Department of Health
1 Name of Instrument
(1) This instrument is the National Health (Weighted average disclosed price – April 2019 reduction day) Amendment Determination 2019.
(2) This instrument may also be cited as PB 9 of 2019.
2 Commencement
This instrument commences on the day after it is registered.
3 Amendments to PB 42 of 2018
Schedule 1 amends the National Health (Weighted average disclosed price – April 2019 reduction day) Determination 2018 (PB 109 of 2018)
Schedule 1 Amendments
after:
1458 | Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | HYOSCINE BUTYLBROMIDE SXP | 10.88 |
insert:
1458A | Hypromellose | Eye drops 3 mg per mL, 10 mL | Application to the Eye | Genteal | 2.08 |
1458B | Hypromellose | Eye drops 3 mg per mL, 10 mL | Application to the Eye | In a Wink Moisturising | 2.08 |